NADPH oxidase-IN-1

• CAT Number: I042454
• CAS Number: 2762405-17-2
• Molecular Formula: C20H27N3O2S
• Molecular Weight: 373.51
• Purity: ≥95%
• Synonyms: (5E)-3-cyclohexyl-5-[[4-[2-hydroxyethyl(methyl)amino]phenyl]methylidene]-1-methyl-2-sulfanylideneimidazolidin-4-one
• InChI: InChI=1S/C20H27N3O2S/c1-21(12-13-24)16-10-8-15(9-11-16)14-18-19(25)23(20(26)22(18)2)17-6-4-3-5-7-17/h8-11,14,17,24H,3-7,12-13H2,1-2H3/b18-14+
• InChIKey: ZRIXYNJXSCQFPE-NBVRZTHBSA-N
• SMILES: CN1/C(=C/C2=CC=C(C=C2)N(C)CCO)/C(=O)N(C1=S)C3CCCCC3

NADPH oxidase-IN-1（Cat No.:I042454）is a small molecule inhibitor that targets NADPH oxidase, an enzyme complex responsible for producing reactive oxygen species (ROS) during immune responses. By inhibiting NADPH oxidase, this compound reduces oxidative stress and inflammation, which are implicated in various chronic diseases, including cardiovascular diseases, neurodegenerative disorders, and autoimmune conditions. NADPH oxidase-IN-1 is being investigated for its potential to treat diseases where excessive ROS production contributes to tissue damage and inflammation. This inhibitor offers a novel approach to modulate oxidative stress and provide therapeutic benefits in related disease settings.